Search Results - "Witherow C"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.

    Authors: Ching THW Stahnke B Shnayder S et al.

    Source: Frontiers in psychiatry [Front Psychiatry] 2025 Dec 10; Vol. 16, pp. 1726818. Date of Electronic Publication: 2025 Dec 10 (Print Publication: 2025).

    Publication Type: Journal Article

    Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.

    Authors: Therriault J Brum WS Trudel L et al.

    Source: The Lancet. Neurology [Lancet Neurol] 2025 Sep; Vol. 24 (9), pp. 740-752.

    Publication Type: Systematic Review; Journal Article; Meta-Analysis

    Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE

    Save to List
  3. 3

    Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.

    Authors: Ching THW Grazioplene R Bohner C et al.

    Source: Frontiers in psychiatry [Front Psychiatry] 2023 Apr 25; Vol. 14, pp. 1178529. Date of Electronic Publication: 2023 Apr 25 (Print Publication: 2023).

    Publication Type: Journal Article

    Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE

    PDF Full Text
    Save to List
  4. 4

    Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.

    Authors: Ching THW Amoroso L Bohner C et al.

    Source: Frontiers in psychiatry [Front Psychiatry] 2024 Jan 09; Vol. 14, pp. 1278823. Date of Electronic Publication: 2024 Jan 09 (Print Publication: 2023).

    Publication Type: Journal Article

    Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE

    PDF Full Text
    Save to List

Search Tools: